Document is current
Any future updates will be listed below
-
Authors
Kuppe, Christoph https://orcid.org/0000-0003-4597-9833
Ramirez Flores, Ricardo O. https://orcid.org/0000-0003-0087-371X
Li, Zhijian https://orcid.org/0000-0002-1523-1333
Hayat, Sikander
Levinson, Rebecca T.
Liao, Xian
Hannani, Monica T. https://orcid.org/0000-0002-4123-6832
Tanevski, Jovan https://orcid.org/0000-0001-7177-1003
Wünnemann, Florian
Nagai, James S.
Halder, Maurice https://orcid.org/0000-0003-2386-9684
Schumacher, David https://orcid.org/0000-0002-2308-6543
Menzel, Sylvia
Schäfer, Gideon
Hoeft, Konrad https://orcid.org/0000-0002-0265-0061
Cheng, Mingbo
Ziegler, Susanne
Zhang, Xiaoting
Peisker, Fabian https://orcid.org/0000-0003-0123-8179
Kaesler, Nadine
Saritas, Turgay https://orcid.org/0000-0002-6691-9218
Xu, Yaoxian
Kassner, Astrid
Gummert, Jan
Morshuis, Michiel
Amrute, Junedh https://orcid.org/0000-0002-6851-0168
Veltrop, Rogier J. A. https://orcid.org/0000-0002-1386-820X
Boor, Peter https://orcid.org/0000-0001-9921-4284
Klingel, Karin
Van Laake, Linda W.
Vink, Aryan https://orcid.org/0000-0002-9371-8788
Hoogenboezem, Remco M.
Bindels, Eric M. J. https://orcid.org/0000-0001-9502-669X
Schurgers, Leon https://orcid.org/0000-0001-7867-6957
Sattler, Susanne https://orcid.org/0000-0001-9932-4109
Schapiro, Denis https://orcid.org/0000-0002-9391-5722
Schneider, Rebekka K.
Lavine, Kory https://orcid.org/0000-0003-1948-9945
Milting, Hendrik
Costa, Ivan G. https://orcid.org/0000-0003-2890-8697
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Kramann, Rafael https://orcid.org/0000-0003-4048-6351
- License Information
-
More Information
Article History
Received: 30 November 2020
Accepted: 29 June 2022
First Online: 10 August 2022
Competing interests
: The authors declare no competing interests directly related to this work. The authors however disclose unrelated funding, honorariums and ownership as follows: R.K. has grants from Travere Therapeutics, Galapagos, Chugai and Novo Nordisk and is a consultant for Bayer, Pfizer, Novo Nordisk and Gruenenthal. J.S.-R. reports funding from GSK and Sanofi and fees from Travere Therapeutics and Astex Therapeutics. K.L. has grants from Novartis and Amgen and receives consulting fees from Medtronic and Implicit Biosciences. I.G.C. has a grant from Illumina. L.S. has received grants from Bayer, Boehringer Ingelheim and Nattopharma, is consultant for ImmunoDiagnostics Systems (IDS) and is a shareholder in Coagulation Profile. L.W.V.L. reports consultancy fees to UMCU from Abbott, Medtronic, Vifor and Novartis.
